Advertisement

Hypersomnia

  • Samata Singhi
  • Erin Steinhart
  • Kiran MaskiEmail author
Chapter

Abstract

Hypersomnia is characterized by irrepressible need for sleep resulting in excessive daytime sleepiness. The diagnosis of hypersomnia assumes that a patient is receiving a sufficient amount of regular nocturnal sleep. While hypersomnia is a relatively rare condition, it has been described in disorders such as primary depression, attention-deficit/hyperactivity disorder, and neurogenetic conditions. Narcolepsy, idiopathic hypersomnia, and Kleine-Levin syndrome represent primary central nervous system disorders characterized by hypersomnia. Narcolepsy in particular can also be associated with neurobehavioral and mood disorders making diagnosis and management complicated. In this chapter, we review primary and secondary causes of hypersomnia, detail clinical diagnostic tools, and discuss commonly used treatments for hypersomnia.

Keywords

Hypersomnia Excessive daytime sleepiness Narcolepsy ADHD Depression Kleine-Levine syndrome Idiopathic hypersomnia Prader-Willi syndrome Smith-Magenis syndrome Polysomnography Multiple sleep latency testing Stimulants Modafinil Sodium oxybate 

References

  1. 1.
    American Academy of Sleep Medicine. The international classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.Google Scholar
  2. 2.
    Silber MH, et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197–202.CrossRefGoogle Scholar
  3. 3.
    Longstreth WT Jr, et al. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26.PubMedCrossRefGoogle Scholar
  4. 4.
    Dement W, Rechtschaffen A, Gulevich G. The nature of the narcoleptic sleep attack. Neurology. 1966;16(1):18–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Krahn LE, et al. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep. 2002;25(7):733–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishino S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40.CrossRefGoogle Scholar
  7. 7.
    Thannickal TC, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469–74.CrossRefGoogle Scholar
  8. 8.
    Mignot E, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997;20(11):1012–20.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Mignot E, et al. Nocturnal sleep and daytime sleepiness in normal subjects with HLA-DQB1*0602. Sleep. 1999;22(3):347–52.PubMedGoogle Scholar
  10. 10.
    Vendrame M, et al. Narcolepsy in children: a single-center clinical experience. Pediatr Neurol. 2008;38(5):314–20.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Wu H, et al. Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in eastern China. Sleep Med. 2014;15(6):607–13.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Guilleminault C, Pelayo R. Narcolepsy in prepubertal children. Ann Neurol. 1998;43(1):135–42.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Plazzi G, et al. Narcolepsy-cataplexy associated with precocious puberty. Neurology. 2006;66(10):1577–9.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Posar A, et al. Neuropsychological findings in childhood narcolepsy. J Child Neurol. 2014;29(10):1370–6.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Morrish E, et al. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med. 2004;5(1):37–41.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15(5):502–7.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol. 2003;114(11):2000–17.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Overeem S, et al. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol. 2001;18(2):78–105.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Aran A, et al. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep. 2010;33(11):1457–64.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Serra L, et al. Cataplexy features in childhood narcolepsy. Mov Disord. 2008;23(6):858–65.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Andlauer O, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep. 2012;35(9):1247–55F.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep. 2009;32(8):993–8.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res. 2000;97(2–3):153–64.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med Rev. 2011;15(5):311–5.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Dauvilliers Y, et al. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med. 2013;11:78.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 2003;53(2):154–66.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Dye TJ, Jain SV, Kothare SV. Central hypersomnia. Semin Pediatr Neurol. 2015;22(2):93–104.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Arnulf I, et al. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain. 2005;128(Pt 12):2763–76.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918–28.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Lavault S, et al. Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol. 2015;77(3):529–40.PubMedCrossRefGoogle Scholar
  31. 31.
    Kas A, et al. Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome. Brain. 2014;137(Pt 7):2077–87.PubMedCrossRefGoogle Scholar
  32. 32.
    Dauvilliers Y, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59(11):1739–45.PubMedCrossRefGoogle Scholar
  33. 33.
    Arnulf I, et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol. 2008;63(4):482–93.PubMedCrossRefGoogle Scholar
  34. 34.
    Sum-Ping O, Guilleminault C. Kleine-Levin syndrome. Curr Treat Options Neurol. 2016;18(6):24.PubMedCrossRefGoogle Scholar
  35. 35.
    Leu-Semenescu S, et al. Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients. Neurology. 2015;85(19):1655–62.PubMedCrossRefGoogle Scholar
  36. 36.
    Hu P, Stylos-Allan M, Walker MP. Sleep facilitates consolidation of emotional declarative memory. Psychol Sci. 2006;17(10):891–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Owens JA. The ADHD and sleep conundrum: a review. J Dev Behav Pediatr. 2005;26(4):312–22.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Stein MA, et al. Sleep and behavior problems in school-aged children. Pediatrics. 2001;107(4):E60.PubMedCrossRefGoogle Scholar
  39. 39.
    Fallone G, Owens JA, Deane J. Sleepiness in children and adolescents: clinical implications. Sleep Med Rev. 2002;6(4):287–306.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Stores G. Sleep studies in children with a mental handicap. J Child Psychol Psychiatry. 1992;33(8):1303–17.PubMedCrossRefGoogle Scholar
  41. 41.
    Omokawa M, et al. Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome. Am J Med Genet A. 2016;170A:1181–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Vossler DG, et al. Cataplexy and monoamine oxidase deficiency in Norrie disease. Neurology. 1996;46(5):1258–61.PubMedCrossRefGoogle Scholar
  43. 43.
    Oyama K, et al. Niemann-Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid. Tohoku J Exp Med. 2006;209(3):263–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Nelson GB, Hahn JS. Stimulus-induced drop episodes in Coffin-Lowry syndrome. Pediatrics. 2003;111(3):e197–202.PubMedCrossRefGoogle Scholar
  45. 45.
    Bioulac S, Micoulaud-Franchi JA, Philip P. Excessive daytime sleepiness in patients with ADHD – diagnostic and management strategies. Curr Psychiatry Rep. 2015;17(8):608.PubMedCrossRefGoogle Scholar
  46. 46.
    Corkum P, Tannock R, Moldofsky H. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(6):637–46.PubMedCrossRefGoogle Scholar
  47. 47.
    Yoon SY, Jain U, Shapiro C. Sleep in attention-deficit/hyperactivity disorder in children and adults: past, present, and future. Sleep Med Rev. 2012;16(4):371–88.PubMedCrossRefGoogle Scholar
  48. 48.
    Hvolby A. Associations of sleep disturbance with ADHD: implications for treatment. Atten Defic Hyperact Disord. 2015;7(1):1–18.PubMedCrossRefGoogle Scholar
  49. 49.
    Cortese S. Sleep and ADHD: what we know and what we do not know. Sleep Med. 2015;16(1):5–6.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Owens JA. Sleep disorders and attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2008;10(5):439–44.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Goraya JS, et al. Sleep study abnormalities in children with attention deficit hyperactivity disorder. Pediatr Neurol. 2009;40(1):42–6.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Cortese S, et al. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009;48(9):894–908.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Cortese S, et al. Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep. 2006;29(4):504–11.PubMedGoogle Scholar
  54. 54.
    Lecendreux M, et al. Sleep and alertness in children with ADHD. J Child Psychol Psychiatry. 2000;41(6):803–12.PubMedCrossRefGoogle Scholar
  55. 55.
    Greenberg F, et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet. 1996;62(3):247–54.PubMedCrossRefGoogle Scholar
  56. 56.
    Smith AC, Dykens E, Greenberg F. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). Am J Med Genet. 1998;81(2):186–91.PubMedCrossRefGoogle Scholar
  57. 57.
    De Leersnyder H. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. Trends Endocrinol Metab. 2006;17(7):291–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Potocki L, et al. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J Med Genet. 2000;37(6):428–33.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Novakova M, et al. Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab. 2012;97(2):E312–8.PubMedCrossRefGoogle Scholar
  60. 60.
    De Leersnyder H, et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr. 2001;139(1):111–6.PubMedCrossRefGoogle Scholar
  61. 61.
    De Leersnyder H, et al. beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2001;38(9):586–90.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Cassidy SB, Schwartz S. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting. Medicine (Baltimore). 1998;77(2):140–51.CrossRefGoogle Scholar
  63. 63.
    Holm VA, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91(2):398–402.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Cotton S, Richdale A. Brief report: parental descriptions of sleep problems in children with autism, Down syndrome, and Prader-Willi syndrome. Res Dev Disabil. 2006;27(2):151–61.PubMedCrossRefGoogle Scholar
  65. 65.
    Richdale AL, Cotton S, Hibbit K. Sleep and behaviour disturbance in Prader-Willi syndrome: a questionnaire study. J Intellect Disabil Res. 1999;43(Pt 5):380–92.PubMedGoogle Scholar
  66. 66.
    Manni R, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001;112(5):800–5.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Bruni O, et al. Prader-Willi syndrome: sorting out the relationships between obesity, hypersomnia, and sleep apnea. Curr Opin Pulm Med. 2010;16(6):568–73.PubMedCrossRefGoogle Scholar
  68. 68.
    Camfferman D, et al. Prader Willi syndrome and excessive daytime sleepiness. Sleep Med Rev. 2008;12(1):65–75.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Sedky K, Bennett DS, Pumariega A. Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med. 2014;10(4):403–9.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Cohen M, Hamilton J, Narang I. Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi syndrome. PLoS One. 2014;9(6):e101012.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Harris JC, Allen RP. Is excessive daytime sleepiness characteristic of Prader-Willi syndrome? The effects of weight change. Arch Pediatr Adolesc Med. 1996;150(12):1288–93.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    De Cock VC, et al. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(7):1552–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Lainhart JE, Folstein SE. Affective disorders in people with autism: a review of published cases. J Autism Dev Disord. 1994;24(5):587–601.PubMedCrossRefGoogle Scholar
  74. 74.
    Leyfer OT, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006;36(7):849–61.PubMedCrossRefGoogle Scholar
  75. 75.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  76. 76.
    Lecendreux M, et al. Attention-deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: a cross-sectional study. Sleep. 2015;38(8):1285–95.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Modestino EJ, Winchester J. A retrospective survey of childhood ADHD symptomatology among adult narcoleptics. J Atten Disord. 2013;17(7):574–82.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Millman RP, Working Group on Sleepiness in Adolescents/Young Adults, AAP Committee on Adolescence. Excessive sleepiness in adolescents and young adults: causes, consequences, and treatment strategies. Pediatrics. 2005;115(6):1774–86.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    O’Brien LM. The neurocognitive effects of sleep disruption in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2009;18(4):813–23.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Kadasah S, Arfin M, Tariq M. HLA-DRB1 association with schizophrenia in Saudi Arabian patients. Int J Psychiatry Clin Pract. 2011;15(2):112–7.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Huang YS, et al. Narcolepsy-cataplexy and schizophrenia in adolescents. Sleep Med. 2014;15(1):15–22.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Auger RR, et al. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep. 2005;28(6):667–72.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Melamed Y, Daliahu Y, Paleacu D. Narcolepsy and psychotic states – a case report. Isr J Psychiatry Relat Sci. 2009;46(1):70–3.PubMedGoogle Scholar
  84. 84.
    Tsutsui K, et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry. 2012;12:37.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Plazzi G, et al. Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics. Neuropsychobiology. 2015;71(4):218–24.PubMedCrossRefGoogle Scholar
  86. 86.
    Fortuyn HA, et al. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry. 2010;32(1):49–56.PubMedCrossRefGoogle Scholar
  87. 87.
    Inocente CO, et al. Depressive feelings in children with narcolepsy. Sleep Med. 2014;15(3):309–14.PubMedCrossRefGoogle Scholar
  88. 88.
    Janowsky DS, et al. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 1972;2(7778):632–5.PubMedCrossRefGoogle Scholar
  89. 89.
    Drake C, et al. The Pediatric Daytime Sleepiness Scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep. 2003;26(4):455–8.Google Scholar
  90. 90.
    Larson AM, et al. Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia. 2012;53(7):1162–9.CrossRefGoogle Scholar
  91. 91.
    Maganti R, et al. Excessive daytime sleepiness and sleep complaints among children with epilepsy. Epilepsy Behav. 2006;8(1):272–7.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Bruni O, et al. Sleep architecture and NREM alterations in children and adolescents with Asperger syndrome. Sleep. 2007;30(11):1577–85.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Spilsbury JC, et al. The Cleveland Adolescent Sleepiness Questionnaire: a new measure to assess excessive daytime sleepiness in adolescents. J Clin Sleep Med. 2007;3(6):603–12.Google Scholar
  94. 94.
    Melendres MC, et al. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics. 2004;114(3):768–75.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Nishiyama T, et al. Criterion validity of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale for the diagnosis of sleep disorders. Sleep Med. 2014;15(4):422–9.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Brimeyer C, et al. Sleep complaints in survivors of pediatric brain tumors. Support Care Cancer. 2016;24:23–31.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Wiebe S, et al. Sleep and sleepiness in children with attention deficit/hyperactivity disorder and controls. J Sleep Res. 2013;22(1):41–9.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Zafar AB, et al. Examining sleep, fatigue, and daytime sleepiness in pediatric multiple sclerosis patients. Mult Scler. 2012;18(4):481–8.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep. 2006;29(8):1025–9.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    De Crescenzo F, Licchelli S, Ciabattini M, Menghini D, Armando M, Alfieri P, Mazzone L, Pontrelli G, Livadiotti S, Foti F, Quested D, Vicari S. The use of actigraphy in the monitoring of sleep and activity in ADHD: a meta-analysis. Sleep Med Rev. 2015;26:9–20.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Gruber R. ADHD, anxiety and sleep: a window to understanding the interplay between sleep, emotional regulation and attention in children. Behav Sleep Med. 2014;12(1):4.CrossRefGoogle Scholar
  102. 102.
    Maski K, et al. Sleep dependent memory consolidation in children with autism Spectrum disorder. Sleep. 2015;38:1955.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Souders MC, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32(12):1566–78.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Gingras P, Grenn D, Wright B, Rush C, Sparrowhawk M, Pratt K, Allgar V, Hooke N, Moore D, Zaiwalla Z, Wiggs L. Weighted blankets and sleep in autistic children – a randomized controlled trial. Pediatrics. 2014;134(2):9.CrossRefGoogle Scholar
  105. 105.
    Fawkes DB, et al. Conducting actigraphy research in children with neurodevelopmental disorders – a practical approach. Behav Sleep Med. 2015;13(3):181–96.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Filardi M, et al. Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence. Sleep Med. 2015;16(1):126–30.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Reiter J, et al. Usefulness of a nocturnal SOREMP for diagnosing narcolepsy with cataplexy in a pediatric population. Sleep. 2015;38(6):859–65.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Goldbart A, et al. Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep. 2014;37(6):1043–51.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Littner MR, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28(1):113–21.CrossRefGoogle Scholar
  110. 110.
    Morgenthaler TI, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705–11.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Billiard M, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol. 2006;13(10):1035–48.PubMedCrossRefGoogle Scholar
  112. 112.
    Rugino T. A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat. 2007;3(3):293–301.PubMedPubMedCentralGoogle Scholar
  113. 113.
    Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med. 2003;4(6):579–82.PubMedCrossRefGoogle Scholar
  114. 114.
    Lecendreux M, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep. 2012;35(5):709–11.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Owens J. Modafinil is well tolerated in children and adolescents with excessive sleepiness and obstructive sleep apnea: a 6-week double-blind study. Sleep. 2007;30(Abstract Supplement):257.Google Scholar
  116. 116.
    Ferraro L, et al. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol. 1996;306(1–3):33–9.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Lecendreux M. Pharmacological management of narcolepsy and cataplexy in pediatric patients. Paediatr Drugs. 2014;16(5):363–72.PubMedCrossRefGoogle Scholar
  118. 118.
    Lecendreux M, et al. Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. J Sleep Res. 2012;21(4):481–3.PubMedCrossRefGoogle Scholar
  119. 119.
    Harsh JR, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin. 2006;22(4):761–74.PubMedCrossRefGoogle Scholar
  120. 120.
    Darwish M, et al. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Clin Ther. 2010;32(12):2074–87.PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology. 2000;54(5):1166–75.Google Scholar
  122. 122.
    Guilleminault C. Amphetamines and narcolepsy: use of the Stanford database. Sleep. 1993;16(3):199–201.PubMedCrossRefGoogle Scholar
  123. 123.
    Narendran R, et al. Is psychosis exacerbated by modafinil? Arch Gen Psychiatry. 2002;59(3):292–3.PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Bayard S, Langenier MC, Dauvilliers Y. Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy. Sleep. 2013;36(9):1335–40.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Moller LR, Ostergaard JR. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol. 2009;19(2):197–201.PubMedCrossRefGoogle Scholar
  126. 126.
    Ratkiewicz M, Splaingard M. Treatment of cataplexy in a three-year-old using venlafaxine. J Clin Sleep Med. 2013;9(12):1341–2.PubMedPubMedCentralGoogle Scholar
  127. 127.
    Mansukhani MP, Kotagal S. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Sleep Med. 2012;13(6):606–10.PubMedCrossRefGoogle Scholar
  128. 128.
    Nevsimalova S. The diagnosis and treatment of pediatric narcolepsy. Curr Neurol Neurosci Rep. 2014;14(8):469.PubMedCrossRefGoogle Scholar
  129. 129.
    Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9(4):739–52.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Thorpy MJ, Westbrook P, Ferber R, Fredrickson P, Mahowald M, Perez-Guerra F, Reite M, Smith P. The clinical use of the multiple sleep latency test. Sleep. 1992;15:9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurologyBoston Children’s HospitalBostonUSA
  2. 2.Clinical Research Operations, Department of NeurologyBoston Children’s HospitalBostonUSA
  3. 3.Harvard Medical SchoolBostonUSA

Personalised recommendations